Vorsitz: P. Ehlermann (Heidelberg), B. Gerull (Würzburg)
(V1172) | Variable expression of myosin-binding protein C resulting in contractile imbalance from cell-to-cell as possible pathogenic trigger in hypertrophic cardiomyopathy | |
D. Aldag-Niebling, A. Radocaj, J. Montag, B. Piep, B. Keyser, C. dos Remedios, D. Hilfiker-Kleiner, B. Brenner, T. Kraft (Hannover; Sydney, AU) | ||
Diskussion | ||
(V1173) | Diltiazem reverses long QT-phenotype of a hypertrophic cardiomyopathy caused by a novel ACTN2 mutation | |
M. Lemoine, M. Prondzynski, A. Horváth, N. Kresin, F. W. Friedrich, J. Münch, M. Patten-Hamel, C. Meyer, T. Christ, T. Eschenhagen, L. Carrier (Hamburg) | ||
Diskussion | ||
(V1174) | Mitochondrial origin of arrhythmias in hypertrophic cardiomyopathy | |
B. Knollmann, M. Kohlhaas, S. Parikh, A. Dietl, F. W. Friedrich, F. Flenner, O. Otto, V. Sequeira, M. Hohl, L. Prades Roma, V. Johnson, R. Venkataraman, J. Bay, A. Nickel, P. Lipp, L. Carrier, T. Eschenhagen, C. Maack (Nashville, US; Würzburg, Regensburg, Hamburg, Homburg/Saar) | ||
Diskussion | ||
(V1175) | Role of adaptive immunity in a mouse model of Duchenne’s cardiomyopathy | |
N. Gladow, M. Rieckmann, G. Ramos, S. Frantz, U. Hofmann (Würzburg, Halle (Saale)) | ||
Diskussion | ||
(V1176) | Modelling PRDM16 related cardiomyopathy with human induced pluripotent stem cell derived cardiomyocytes | |
J. Kühnisch, D. Romaker, J. Dartsch, A.-K. Kahlert, A. Hansen, S. Diecke, C. MacRae, N. Hübner, S. Klaassen (Berlin, Kiel, Hamburg; Boston, US) | ||
Diskussion | ||
(V1177) | Dysfunction of VARS2 leads to dilated cardiomyopathy (DCM) | |
E. Kayvanpour, M. Lackner, F. Sedaghat-Hamedani, J.-N. Boeckel, K. S. Frese, J. Haas, H. A. Katus, B. Meder (Heidelberg) | ||
Diskussion | ||
(V1178) | Interplay of HMGB1 with soluble MD-2 in dilated cardiomyopathy and its impact in immune cell recruitment |
|
A. Kümmel, R. Feldtmann, A. Strohbach, A. Riad, B. Chamling, S. B. Felix (Greifswald, Teterow) | ||
Abschlussdiskussion | ||
(V1179) | Occurrence of ventricular tachyarrhythmias and progression of cardiomyopathy in patients with muscular dystrophy – a CMR-based follow-up study | |
A. R. Florian, M. Bietenbeck, C. Meier, V. Holtstiege, G. Chatzantonis, A. Yilmaz (Münster) | ||
Abschlussdiskussion | ||
(V1180) | Truncated titin-protein species due to truncating mutations in the TTN gene are expressed in human DCM hearts and can be modulated by manipulating the cellular protein quality control systems | |
A. Fomin, A. Gärtner-Rommel, L. Cyganek, M. von Frieling-Salewsky, A. Goedel, A. Moretti, H. Milting, W. A. Linke (Göttingen, Bad Oeynhausen, Münster, München) | ||
Diskussion |
10:00 - 11:30 | Pause - Posterdiskussion |